EQX Labs and the Tokenized Stock Mirage: A Forensic Teardown of Hyperliquid's HIP-1 Gambit

Every tokenized stock EQX Labs plans to issue on Hyperliquid carries a gap. It is small. It is documented. It is fatal under the right conditions.

The mechanism is called "in transit." A buyer purchases a token backed by a US equity. The token settles on-chain instantly. The underlying share does not. It settles on the next US business day. For that window — hours, sometimes a weekend — the token exists without its backing. The 1:1 claim degrades to 1:0.9997, then to whatever the market decides it is worth while the collateral is airborne.

This is not a bug. It is a disclosed feature. That is worse. A hidden flaw can be fixed in silence. A disclosed one becomes a permanent property of the system, priced in, rationalized, and eventually ignored. The gap is not the scandal. The normalization of the gap is.

I have spent a decade watching tokenized assets promise settlement finality they cannot deliver. The code spoke, but the logic was a lie. This is the same lie, restated with better architecture.

EQX Labs is issuing tokenized US equities on Hyperliquid using the HIP-1 standard — Hyperliquid's permissionless spot token standard. Eleven markets are planned. None are live. Every fact below comes from EQX Labs itself. No third party has verified anything. That is the first thing to internalize before reading a single technical detail.

Hyperliquid is a decentralized perpetuals exchange that runs its own Layer 1. The core execution layer, HyperCore, hosts the order book. HIP-1 lets anyone deploy a spot token that trades against Hyperliquid's shared liquidity. EQX uses this to issue stock-backed instruments natively — not as ERC-20s on Ethereum, not as SPL tokens on Solana, but as first-class citizens of Hyperliquid's own chain.

The pitch is seductive. Twenty-four-hour trading. No permission required. Zero fees on creation, redemption, and holding. Trading costs are just Hyperliquid's standard spot fee. The issuer does not charge users. It earns a share of trading fees, split with Hyperliquid.

Tokenized stocks are not new. Backed Finance runs xStocks across Kraken and Solana. Ondo Finance dominates tokenized treasuries. Dinari sells dShares through a US-compliant path. Robinhood EU has retail distribution. EQX is late. Its differentiation is not the asset. It is the rail.

Then the details start to leak.

The report discloses no smart contract audit. None. For a system that will custody claims on US equities, this is not an oversight. It is a signal. In my own audit work, I have learned that the absence of an audit is almost never a timing problem. It is a cost decision or a risk decision. Neither is reassuring. A project that has spent the capital to build a BVI issuer, a Cayman trust, and DTC-connected custodians has not run out of money for a security review. It has run out of appetite.

The full feature set depends on an unfinished dependency. EQX promises direct dividend distribution, on-chain voting, and stock splits. All three require a "proposed" HIP-1 extension. Read the word again. Proposed. Not deployed. Not audited. Proposed. The product being marketed is not the product that exists. The product that exists trades. The product that is promised does more. The distance between them is technical debt wearing a roadmap.

A dividend feature that depends on a proposed protocol upgrade is not a feature. It is a forecast.

Then the permission structure. EQX markets "permissionless trading." True at the secondary layer. False at the primary. Shares and tokens are created and redeemed by Authorized Participants — the ETF mechanism, imported wholesale into a venue that advertises the absence of gatekeepers. Retail trades freely. Institutions gate the mint. This is a two-tier market wearing a decentralized costume. The permission is real. It is simply not where the marketing points.

The settlement mismatch deserves its own accounting. On-chain settlement is atomic. US equity settlement is T+1. These two clocks cannot be synchronized, so EQX does what every honest bridge does: it parks the discrepancy in a labeled bucket. "In transit." The label is accurate. The exposure is real. During the in-transit window, the holder owns a claim on a share that has not yet arrived. If the custodian fails, or the trade breaks, or a corporate action lands mid-flight, the token holder is holding a promise about a settlement that has not occurred.

The 1:1 backing is not a constant. It is a function of time, and it spends part of every week below one.

The instrument is not a token. It is a limited recourse note. That phrase matters more than any line of code. A holder has recourse to a specific portfolio's assets and nothing else. No claim on EQX as a whole. If the issuer defaults, the holder recovers from one segregated pool and stops there. This is a Segregated Portfolio Company structure — a BVI issuer, a Cayman trust holding it. Bankruptcy isolation is the legal term. Risk pushdown is the honest one.

Supply is elastic. No fixed cap. Mint on subscription, burn on redemption, one to one. No inflation schedule, no unlock cliff, no vesting calendar. The traditional tokenomics framework does not apply here, and pretending it does would be a category error. There is no team allocation because there is no governance token. There is no treasury because there is no protocol revenue routed to a token. The value comes from the underlying equity and its dividends. That is the entire thesis, and it is a borrowed thesis.

The business model is a fee split. EQX does not charge users. It takes a cut of Hyperliquid's trading fees as the HIP-1 deployer. This is a Web2 playbook — zero price to capture flow, monetize the flow later. It works at volume. It bleeds at low volume. Eleven new markets starting from zero liquidity, with makers expected to fund depth across all of them simultaneously, is a cold-start problem EQX has not addressed in any public document. And the fee-split ratio? Undisclosed.

Zero fees are not generosity. They are a bet that volume will arrive before the cash runs out.

Now the regulatory layer, which is the highest-risk surface in the entire structure. Apply the Howey test. Money invested: yes. Common enterprise: yes. Expectation of profit: yes — price appreciation plus reinvested dividends. Efforts of others: partially — price comes from the market, but dividends, splits, and custody depend on the issuer. The conclusion is not close. Tokenized US equities are securities in most frameworks. The instrument is named "notes," not "shares," and that naming is a regulatory posture, not a legal shield. A note whose underlying is a security is, in most jurisdictions, still a security.

The structure is offshore by design. A BVI SPC issues. A Cayman purpose trust holds the issuer. EQX Labs does not own the issuing entity. This is legal distance. It is also accountability distance. When a regulator looks for the responsible party, the structure points at a trust with undisclosed beneficiaries. That is not a defense. It is a maze.

The permissionless trading layer collides with securities law head-on. Securities trading requires licensing, KYC, and suitability review. EQX advertises the absence of permission. That is the fault line. The US custodians connecting to DTC — Alpaca, StoneX, Clear Street — hold the underlying shares. US-regulated entities holding collateral for an offshore, permissionless securities product is a transmission channel for regulatory risk in both directions. A single enforcement action against the custodian propagates directly into the token.

There is no KYC/AML disclosure. None. A permissionless trading venue and a securities instrument cannot both be true statements about the same product. Something has to give, and the disclosure is silent on which side gives.

The team is undisclosed. Founder, technical lead, funding — all absent. For a securities product, this is a major information asymmetry. There is no way to assess competence, incentives, or alignment. I have published reports that halted mainnet launches because the code could not survive contact with scrutiny. I cannot apply that standard here, because there is no code to read and no team to question. The absence of a target is not the absence of a risk.

Governance is a signature-based on-chain vote. The efficacy of that vote is undisclosed. Consultative or binding? Unknown. For stock-backed notes, holder votes usually route through the issuer as proxy. The on-chain signature may be theater. The actual power sits in a Cayman trust with unnamed controllers. Trust is a variable you cannot hardcode — and here it has not even been parameterized.

The risk is not technical. It is regulatory and informational. Three layers stack: no audit, no team disclosure, no independent verification of the 1:1 backing. The asset has real collateral, which removes ponzi risk. It does not remove the risk that the collateral is misrepresented, the custodian fails, or a regulator shuts the rail. Real backing protects against fraud. It does not protect against law.

Now the part the bears miss.

I have spent enough time dismantling this to be fair about what is actually new, and two things are.

First, the issuance rail. Almost every RWA project issues on a general-purpose chain as ERC-20 or SPL. EQX issues natively on HyperCore. That means the tokens share Hyperliquid's public order book and its existing liquidity. No bridge. No wrapped asset. No separate AMM. The token is a first-class citizen of the venue where it trades. If this model works, it changes the default for RWA issuance — not because the asset is new, but because the distribution is native. That is a genuine architectural choice, and it deserves to be named as one.

Second, the settlement window. The "in transit" gap is a flaw. It is also the honest acknowledgment of a real problem. On-chain settlement is instant. US equity settlement is T+1. The two systems do not reconcile, and no amount of branding will make them. Most tokenized stock projects hide this mismatch behind opaque redemption terms. EQX surfaces it. A disclosed gap is still a gap. It is not a lie. That distinction matters. The signature line applies to projects that hide their mismatches. EQX is not hiding this one. It is naming it, which is more than most of its competitors have the discipline to do.

And twenty-four-hour trading is genuinely differentiated against a broker that closes on Friday afternoon. The problem is that every tokenized stock competitor offers the same thing. Real advantage, zero exclusivity. The feature is not a moat. It is table stakes, and EQX is arriving to a table that is already full.

The questions that matter are simple. Who audits the contracts? Who is behind the trust? What are the eleven tickers? What is the fee split? Until those are answered, the 1:1 claim is a promise, not a proof. They built a palace on a fault line, and the blueprints are still under revision. Data does not lie, but it does not care — and right now there is almost no data that did not come from the seller.

Watch the order books when the markets open. Watch the premium. Watch whether the US custodians stay. The gap will tell you everything the press release did not.